Keyphrases
Positron Emission Tomography
100%
Cervical Cancer
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Lymph Node Staging
100%
Supraclavicular
33%
Nodal Disease
33%
Disease-specific Survival
33%
Hazard Ratio
16%
Disease Progression
16%
Working Diagnosis
16%
Progression-free Survival
16%
Historical Data
16%
Chemotherapy
16%
Computed Tomography
16%
Prospective Cohort Study
16%
18F-fluorodeoxyglucose (18F-FDG)
16%
Surgery Alone
16%
Lymph Node Metastasis
16%
Lymph Node Involvement
16%
Patient Demographics
16%
Disease Risk
16%
Group-based
16%
Recurrent Disease
16%
Intraoperative Radiation Therapy
16%
Survival Outcomes
16%
Surgical Series
16%
Definitive Radiation
16%
Nodal Involvement
16%
Positive Lymph Nodes
16%
Negative Lymph Nodes
16%
Medicine and Dentistry
Positron Emission Tomography
100%
Lymph Node
100%
Cervical Cancer
100%
Polyethylene Terephthalate
100%
Clinical Stage
20%
Recurrent Disease
20%
Disease Specific Survival
20%
Hazard Ratio
10%
Progression Free Survival
10%
Disease Exacerbation
10%
Pelvis
10%
Computer Assisted Tomography
10%
Prospective Cohort Study
10%
Lymph Node Metastasis
10%
Fluorodeoxyglucose F 18
10%
Retrospective Study
10%
Patient Population
10%
Pelvic Disease
10%
Diseases
10%
Radiation Therapy
10%